ZyVersa Therapeutics Inc (ZVSA)
1.08
-0.05
(-4.42%)
USD |
NASDAQ |
Nov 15, 16:00
1.06
-0.02
(-1.85%)
After-Hours: 20:00
ZyVersa Therapeutics Net Income (Quarterly): -2.764M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -2.764M |
| March 31, 2024 | -2.827M |
| December 31, 2023 | -13.34M |
| September 30, 2023 | -2.902M |
| June 30, 2023 | -78.51M |
| March 31, 2023 | -3.544M |
| Date | Value |
|---|---|
| December 31, 2022 | -4.602M |
| September 30, 2022 | -3.693M |
| June 30, 2022 | -2.004M |
| March 31, 2022 | -3.748M |
| December 31, 2021 | -1.969M |
| September 30, 2021 | -1.880M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-78.51M
Minimum
Jun 2023
-1.880M
Maximum
Sep 2021
-10.15M
Average
-3.223M
Median
Net Income (Quarterly) Benchmarks
| NeuroBo Pharmaceuticals Inc | -5.652M |
| Dermata Therapeutics Inc | -2.829M |
| Cognition Therapeutics Inc | -7.041M |
| NovaBay Pharmaceuticals Inc | -1.212M |
| Palatin Technologies Inc | -8.250M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.754M |
| EPS Diluted (Quarterly) | -3.31 |
| Enterprise Value | 0.9921M |
| Earnings Yield | -6.69K% |